-+ 0.00%
-+ 0.00%
-+ 0.00%

UNITED THERAPEUTICS CORP: PHASE 3 ADVANCE OUTCOMES STUDY MET ITS PRIMARY ENDPOINT

Reuters·05/17/2026 18:15:20

Please log in to view news